Literature DB >> 7447428

Gentamicin uptake in wild-type and aminoglycoside-resistant small-colony mutants of Staphylococcus aureus.

M H Miller, S C Edberg, L J Mandel, C F Behar, N H Steigbigel.   

Abstract

Gentamicin uptake and killing were studied in aminoglycoside-susceptible wild-type Staphylococcus aureus strains and aminoglycoside-resistant small-colony mutants selected by gentamicin from these strains. In wild-type S. aureus three phases of gentamicin accumulation were noted, and killing occurred during the last and most rapid phase of uptake. Uptake and killing were abolished by anaerobic growth and sodium azide, suggesting that energy-dependent active drug transport required respiration. Treatment of wild-type strains with the uncouplers N,N'-dicyclohexyl carbodiimide (DCCD) and carbonyl cyanide-m-chlorophenyl hydrazone showed disparate effects on gentamicin uptake, producing enhanced and diminished accumulations, respectively. Small-colony mutants demonstrated markedly deficient uptake compared with the wild-type strains and were not killed by gentamicin in concentrations up to 10 mug/ml. Several classes of aminoglycoside-resistant mutant strains are described. One mutant strain was a menadione auxotroph which, when grown in the presence of menadione, exhibited normal gentamicin uptake and killing. Gentamicin uptake and killing in this strain were abolished by KCN when the strain was grown in a medium supplemented with menadione. The membrane adenosine triphosphatase inhibitor DCCD was lethal for this mutant but not for other mutants or wild-type strains. Preincubation with menadione prevented the lethal effect of DCCD, and this strain demonstrated normal gentamicin accumulation when exposed to both DCCD and menadione. A second mutant strain demonstrated both gentamicin uptake and killing in the presence but not the absence of DCCD. Studies with small-colony mutants of S. aureus indicated that the defect in aminoglycoside uptake is very likely related to an inability to generate or maintain energized membranes from respiration. These studies suggest that the membrane energization associated with active aminoglycoside accumulation requires electron transport for the generation of a protonmotive force.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7447428      PMCID: PMC284082          DOI: 10.1128/AAC.18.5.722

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

1.  Antibiotic sensitivity testing. Report of an international collaborative study.

Authors:  H M Ericsson; J C Sherris
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

2.  Accumulation of neutral amino acids by Streptococcus faecalis. Energy coupling by a proton-motive force.

Authors:  S S Asghar; E Levin; F M Harold
Journal:  J Biol Chem       Date:  1973-08-10       Impact factor: 5.157

3.  Beta-galactoside transport and proton movements in an adenosine triphosphatase-deficient mutant of Escherichia coli.

Authors:  B P Rosen
Journal:  Biochem Biophys Res Commun       Date:  1973-08-21       Impact factor: 3.575

4.  Coupling between energy conservation and active transport of serine in Escherichia coli.

Authors:  G van Thienen; P W Postma
Journal:  Biochim Biophys Acta       Date:  1973-10-25

5.  Restoration of active transport in an Mg2+-adenosine triphosphatase-deficient mutant of Escherichia coli.

Authors:  B P Rosen
Journal:  J Bacteriol       Date:  1973-12       Impact factor: 3.490

6.  Role of menaquinone in nitrate respiration in Staphylococcus aureus.

Authors:  A Sasarman; P Purvis; V Portelance
Journal:  J Bacteriol       Date:  1974-02       Impact factor: 3.490

7.  Classification of vitamin K-deficient mutants of Staphylococcus aureus.

Authors:  A Săsărman; M Surdeanu; V Portelance; R Dobardzic; S Sonea
Journal:  J Gen Microbiol       Date:  1971-02

8.  Separation of vitamin K2 isoprenologues by reversed-phase thin-layer chromatography.

Authors:  R K Hammond; D C White
Journal:  J Chromatogr       Date:  1969-12-23

9.  Dwarf-colony variants of Staphylococcus aureus resistant to aminoglucoside antibiotics and to a fatty acid.

Authors:  R W Lacey
Journal:  J Med Microbiol       Date:  1969-08       Impact factor: 2.472

10.  Inhibition of membrane transport in Streptococcus faecalis by uncouplers of oxidative phosphorylation and its relationship to proton conduction.

Authors:  F M Harold; J R Baarda
Journal:  J Bacteriol       Date:  1968-12       Impact factor: 3.490

View more
  46 in total

1.  In vitro antibacterial activities of platelet microbicidal protein and neutrophil defensin against Staphylococcus aureus are influenced by antibiotics differing in mechanism of action.

Authors:  Y Q Xiong; M R Yeaman; A S Bayer
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Escherichia coli variants in periprosthetic joint infection: diagnostic challenges with sessile bacteria and sonication.

Authors:  Parham Sendi; Reno Frei; Thomas B Maurer; Andrej Trampuz; Werner Zimmerli; Peter Graber
Journal:  J Clin Microbiol       Date:  2010-03-24       Impact factor: 5.948

Review 3.  The mode of action of quinolones: the paradox in activity of low and high concentrations and activity in the anaerobic environment.

Authors:  C S Lewin; I Morrissey; J T Smith
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

Review 4.  Molecular mechanisms of drug resistance.

Authors:  J D Hayes; C R Wolf
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

5.  CtaA of Staphylococcus aureus is required for starvation survival, recovery, and cytochrome biosynthesis.

Authors:  M O Clements; S P Watson; R K Poole; S J Foster
Journal:  J Bacteriol       Date:  1999-01       Impact factor: 3.490

6.  Mutations in aarE, the ubiA homolog of Providencia stuartii, result in high-level aminoglycoside resistance and reduced expression of the chromosomal aminoglycoside 2'-N-acetyltransferase.

Authors:  M R Paradise; G Cook; R K Poole; P N Rather
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

7.  Tomatidine inhibits replication of Staphylococcus aureus small-colony variants in cystic fibrosis airway epithelial cells.

Authors:  Gabriel Mitchell; Mariza Gattuso; Gilles Grondin; Éric Marsault; Kamal Bouarab; François Malouin
Journal:  Antimicrob Agents Chemother       Date:  2011-02-28       Impact factor: 5.191

8.  Comparing the microbiota of the cystic fibrosis lung and human gut.

Authors:  Geraint B Rogers; Mary P Carroll; Lucas R Hoffman; Alan W Walker; David A Fine; Kenneth D Bruce
Journal:  Gut Microbes       Date:  2010-01-29

Review 9.  Antimicrobial resistance of Staphylococcus aureus: genetic basis.

Authors:  B R Lyon; R Skurray
Journal:  Microbiol Rev       Date:  1987-03

10.  Susceptibility of Staphylococcus aureus growing on fibronectin-coated surfaces to bactericidal antibiotics.

Authors:  C Chuard; P Vaudaux; F A Waldvogel; D P Lew
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.